American Bio Medica Corporation announced in connection with the Sale, Melissa A. Waterhouse, the principal financial officer of the company, agreed to enter into an employment agreement with the Buyer. Therefore, the employment agreement with the company's principal financial officer, Melissa Waterhouse, was terminated effective March 1, 2023. Ms. Waterhouse has agreed to provide consulting services for the company for up to three months, or until June 1, 2023 to assist with the company's financial reporting obligations and to assist with the company's efforts to secure a new line of business and enter into possible business combinations using the company's publicly traded stock as transaction consideration thereby enhancing shareholder value.
American Bio Medica Corporation
Equities
ABMC
US0246001087
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -.--% |
2023 | American Bio Medica Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2023 | American Bio Medica Corporation Auditor Raises 'Going Concern' Doubt | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 4.81K | |
-8.25% | 11.98B | |
-5.68% | 8B | |
+7.08% | 5.85B | |
+28.87% | 5.54B | |
-15.84% | 3.84B | |
+10.70% | 2.66B | |
-60.92% | 2.62B | |
-8.06% | 2.33B | |
-8.85% | 1.78B |
- Stock Market
- Equities
- ABMC Stock
- News American Bio Medica Corporation
- American Bio Medica Corporation Announces Termination of Melissa A. Waterhouse as Principal Financial Officer